Interactions médicamenteuses
Amivantamab + Lazertinib
Gravité: Modérée
Amivantamab and Lazertinib: moderate interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Amivantamab with lazertinib raises the risk of venous thromboembolism, and prophylaxis is recommended. Vitamin K antagonists are poorly suited for this because their variable effect makes control difficult, whereas the interaction concerns the combination's thrombotic risk.
Ce que signifie cette interaction, en termes simples
Amivantamab and Lazertinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Amivantamab belongs to Oncology; Lazertinib belongs to Oncology.
Pourquoi elle survient
The combination increases thromboembolic risk by an incompletely established mechanism.
Conduite à tenir
Give anticoagulant prophylaxis during the first months of therapy, preferably with a direct oral anticoagulant or low molecular weight heparin rather than a vitamin K antagonist. Monitor for signs of VTE.
Questions à poser à votre pharmacien
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Amivantamab et Lazertinib, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Questions fréquentes
Can I take Amivantamab with Lazertinib?
MediHelp rates the interaction as moderate. Amivantamab and Lazertinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Amivantamab with lazertinib raises the risk of venous thromboembolism, and prophylaxis is recommended. Vitamin K antagonists are poorly suited for this because their variable effect makes control difficult, whereas the interaction concerns the combination's thrombotic risk.
How serious is the interaction between Amivantamab and Lazertinib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Give anticoagulant prophylaxis during the first months of therapy, preferably with a direct oral anticoagulant or low molecular weight heparin rather than a vitamin K antagonist. Monitor for signs of VTE.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
